FlowMD Feasibility Study
ConditionAnxiety
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorNational University of Natural Medicine
About this trial
The goal of this clinical trial is to learn if the FlowMD mobile app is feasible to be used to manage mild anxiety in adults. It will also learn if the app is effective at managing anxiety in adults.
Participants will:
Use the FlowMD app daily to complete a 1-5 minute guided breathwork session over the course of 4 weeks.
Complete surveys at the beginning, midpoint, and end of the study to measure anxiety levels and usability of the app.
Eligibility criteria
Qualifiers
Are 18-65 years old
Have an anxiety disorder
Have a smartphone
Able to download the FlowMD app
Disqualifiers
Are undergoing significant changes in psychiatric medication or therapy
Have severe psychiatric conditions that might interfere with study participation (Schizophrenia, Bipolar Disorder, Major Depressive Disorder)
Trial design
Treatments tested in this trial
- Intervention
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov